RT Journal Article
SR Electronic
T1 Dicere Non Nocere: Public Disclosure of Identifiable Patient Information by Health Professionals on Social Media
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.05.20031526
DO 10.1101/2020.03.05.20031526
A1 Katz, Matthew S.
A1 Ahmed, Wasim
A1 Gutheil, Thomas G.
A1 Jagsi, Reshma
YR 2020
UL http://medrxiv.org/content/early/2020/03/06/2020.03.05.20031526.abstract
AB Background Respecting patient privacy and confidentiality is critical for doctor-patient relationships and public trust in medical professionals. The frequency of potentially identifiable disclosures online during periods of active engagement is unknown. Our aim was to quantify potentially identifiable content shared by physicians and other health care providers on social media using the hashtag #ShareAStoryInOneTweet.Methods We used Symplur Signals software to access Twitter’s API and searched for tweets including the hashtag. We identified 1206 tweets by doctors, nurses, and other health professionals out of 43,374 tweets shared May 1-31, 2018. We evaluated tweet content in January 2019, eight months after the study period. To determine the incidence of sharing names or potentially identifiable information about patients, we performed a content analysis of the 754 tweets in which tweets disclosed information about others. We also evaluated whether participants raised concerns about privacy breaches and estimated the frequency of deleted tweets. We used dual, blinded coding for a 10% sample to estimate inter-coder reliability for potential identifiability of tweet content using Cohen’s kappa statistic.Results 656 participants, including 486 doctors (74.1%) and 98 nurses (14.9%), shared 754 tweets disclosing information about others rather than themselves. Professional participants sharing stories about patient care disclosed the time frame in 95 (12.6%) and included patient names in 15 (2.0%) of tweets. We estimated that friends or families could likely identify the clinical scenario described in 32.1% of the 754 tweets. Among 348 tweets about potentially living patients, we estimated 162 (46.6%) were likely identifiable by patients. Inter-coder reliability in rating the potential identifiability demonstrated 86.8% agreement, with a Cohen’s Kappa of 0.8 suggesting substantial agreement Of the 1206 tweets we identified, 78 (6.5%) had been deleted on the website but were still viewable in the analytics software dataset.Conclusions During periods of active sharing online, nurses, physicians, and other health professionals may sometimes share more information than patients or families might expect. More study is needed to determine whether similar events arise frequently online and to understand how to best ensure that patients’ rights are adequately respected.Competing Interest StatementDr. Katz reports common stock ownership in Dr. Reddy’s Laboratories, Healthcare Services Group, Mazor Robotics, and U.S. Physical Therapy. Dr. Jagsi reports stock options as compensation for her advisory board role for Equity Quotient, a company that evaluates culture in health care companies. She has received personal fees from Amgen and Vizient for consulting, fees from the Greenwall Foundation for service as a grant reviewer, and grants for unrelated work from the National Institutes of Health, the Doris Duke Foundation, the Greenwall Foundation, the Susan G. Komen Foundation, and Blue Cross Blue Shield of Michigan for the Michigan Radiation Oncology Quality Consortium.Funding StatementSelf-funded, no grants or industry funding.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data were obtained from the Twitter API through analytics software, Symplur Signals.